PharmaEngine, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Astellas Advances IO Ambitions With Two

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Onivyde (irinotecan liposome injection) is approved and marketed for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based the

The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between October 14 and October 20, 2016, d